examples of glp-1 drugs Agonists Examples: Which One Wins? GLP-1 Medications Infographic | Medidex

The most prevalent factors employers take into consideration for GLP-1 drug coverage for obesity care include: Obesity as a risk factor for chronic conditions and associated costs67% Drug shortages47% Impact/effectiveness of cost-control mechanisms47% Existing coverage through government programs40% Long-term costs33% Patient and prescriber demand33%

Hansoh Pharmaceuticals GLP-1/GIP dual agonist HS-20094, targeting overweight or obesity, has also entered Phase II clinical trials

W., Lingvay, I., Reed, J., De La Rosa, R., Rose, L., Sugimoto, D., Araki, E., Chu, P

In the STEP TEENS trial, GI events affected 62% of participants on semaglutide versus 42% on placebo [4]

Indeed, peripheral insulin levels are ~2-fold higher in patients with T1D compared to patients matched for hyperglycemia (33)

Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study